Colchicine in Acute Myocardial InfarctionSanjit S. Jolly, Salim Yusuf, Marc-André d’Entremont et al.|New England Journal of Medicine|2024Cited by 289
Routine Spironolactone in Acute Myocardial InfarctionSanjit S. Jolly, Salim Yusuf, Marc-André d’Entremont et al.|New England Journal of Medicine|2024Cited by 47
Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial InfarctionShamir R. Mehta, Asim N. Cheema, Jia Wang et al.|JAMA Cardiology|2022Cited by 34
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarctionMarc-André d’Entremont, Sanjit S. Jolly, Shun Fu Lee et al.|American Heart Journal|2024Cited by 31
TCT-240 The Device Success Algorithm of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prospectively Applied to Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in the International Multivessel TALENT Randomized TrialPruthvi C. Revaiah, Patrick Serruys, Faisal Sharif et al.|Journal of the American College of Cardiology|2024Cited by 0